ThinkEquity Starts Emergent BioSolutions (EBS) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.44 -5.43%
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Rating Summary:
12 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 23 | Down: 26 | New: 23
Join SI Premium – FREE
ThinkEquity initiates coverage on Emergent BioSolutions (NYSE: EBS) with a Buy. PT $26.00.
For more ratings news on Emergent BioSolutions click here and for the rating history of Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.98 yesterday.
For more ratings news on Emergent BioSolutions click here and for the rating history of Emergent BioSolutions click here.
Shares of Emergent BioSolutions closed at $16.98 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Emergent BioSolutions (EBS) Misses Q3 EPS by 23c
- Wedbush Starts Terrestrial Energy Inc. (IMSR) at Neutral
- Nomura/Instinet Starts Page Industries Ltd. (PAG:IN) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
